Suppr超能文献

锝标记的甘露糖基化葡聚糖DCM20

Tc-Labeled mannosylated dextran DCM20

作者信息

Shan Liang

机构信息

National Center for Biotechnology Information, NLM, NIH

Abstract

Tc-Labeled mannosylated dextran DCM20, abbreviated as Tc(CO)-DCM20, is a dextran derivative bearing -derivatized cysteine chelator and mannose moieties. Tc(CO)-DCM20 was synthesized by Pirmettis et al. for sentinel lymph node (SLN) detection (1). SLN is defined as the first node in the lymphatic basin that receives the primary lymphatic flow. The concept of SLN is embedded with the notion that the metastatic spread of solid tumors through lymphatic vessels follows a predictable pattern, i.e., tumor cells metastasize to the first lymph node encountered by lymphatic draining from the primary tumor (the SLN), followed by the second- and third-tier lymph nodes; being able to determine the status of the SLN with or without metastatic involvement would allow accurate prediction of the status of the entire regional lymphatic basin draining the tumor (2). Based on this concept, a SLN free from tumor metastasis would exclude tumor spread to the at-risk regional lymphatic basin, rendering nodal basin dissection unnecessary and avoiding the immediate and late complications caused by nodal dissection (3). The concept of SLN has now been widely accepted in clinical practice, and the technology for guided SLN biopsy has been evolving rapidly. Compared with other methods, γ-probe–guided SLN biopsy appears to be more cost-effective, and substantial work has been done in developing optimal imaging techniques and radiotracers to visualize the lymphatic channels leading from the site of tracer administration to the corresponding lymph nodes and to identify the SLN encountered along the lymphatic pathway (2, 3). Currently, three types of radiocolloid preparations are commonly used for lymphoscintigraphy combined with intraoperative γ-probe SLN identification. The Tc-sulfur colloid is the most commonly used probe in the United States (2). The probes are given through peritumoral, periareolar, or dermal injection; from the injection site, the probe particles migrate into the lymphatic vessels by passive diffusion. For most probes, intranodal retention is a process of active, saturable phagocytosis of the macrophages lining the sinusoid spaces of lymph nodes (4, 5). The particle size and surface characteristics of probes influence not only the rate of colloid drainage from the injection site to the lymphatic capillaries but also the phagocytosis by lymph node macrophages. Particles <5 nm easily leak into the bloodstream, whereas particles >100 nm are often trapped in the interstitial space, resulting in masking of the SLN (1, 2, 6). Studies have shown that introduction of mannose molecules to Tc-labeled macromolecules like albumin, polylysine, and dextrans enhances the retention of these probes in the SLN in a saturable mode because of the recognition by the mannose receptors of lymph node macrophages, even though the particles are only a few nanometers in size (7, 8). Pirmettis et al. synthesized a mannosylated nanocompound DCM20, which has a dextran backbone, -derivatized cysteines as a chelator for labeling with the [Tc(CO)] core, and mannose moieties for binding with mannose receptors (1). The radiolabeled DCM20 (Tc(CO)-DCM20) exhibited fast injection site clearance and high uptake and retention in the SLN. This chapter summarizes the data obtained with Tc(CO)-DCM20.

摘要

锝标记的甘露糖基化葡聚糖DCM20,简称为Tc(CO)-DCM20,是一种带有衍生化半胱氨酸螯合剂和甘露糖部分的葡聚糖衍生物。Tc(CO)-DCM20由皮尔梅蒂斯等人合成用于前哨淋巴结(SLN)检测(1)。前哨淋巴结被定义为淋巴引流区域中接受初级淋巴流的第一个淋巴结。前哨淋巴结的概念基于这样一种观念,即实体瘤通过淋巴管的转移扩散遵循可预测的模式,也就是说,肿瘤细胞转移至从原发肿瘤引流的淋巴所遇到的第一个淋巴结(前哨淋巴结),随后转移至二级和三级淋巴结;能够确定前哨淋巴结有无转移受累情况将有助于准确预测引流肿瘤的整个区域淋巴引流区的状态(2)。基于这一概念,无肿瘤转移的前哨淋巴结可排除肿瘤扩散至有风险的区域淋巴引流区,从而无需进行淋巴结清扫,并避免淋巴结清扫引起的近期和远期并发症(3)。前哨淋巴结的概念现已在临床实践中广泛接受,前哨淋巴结活检引导技术也在迅速发展。与其他方法相比,γ探头引导的前哨淋巴结活检似乎更具成本效益,并且在开发最佳成像技术和放射性示踪剂以可视化从示踪剂注射部位通向相应淋巴结的淋巴管以及识别沿淋巴途径遇到的前哨淋巴结方面已经开展了大量工作(2,3)。目前,三种类型的放射性胶体制剂常用于淋巴闪烁显像联合术中γ探头识别前哨淋巴结。锝硫胶体是美国最常用的探头(2)。探头通过瘤周、乳晕周围或皮内注射给药;从注射部位开始,探头颗粒通过被动扩散进入淋巴管。对于大多数探头而言,淋巴结内滞留是淋巴结窦状隙内衬巨噬细胞进行主动、可饱和吞噬的过程(4,5)。探头的颗粒大小和表面特性不仅影响胶体从注射部位引流至淋巴毛细血管的速率,还影响淋巴结巨噬细胞的吞噬作用。小于5纳米的颗粒容易漏入血流,而大于100纳米的颗粒常被困在间质间隙,导致前哨淋巴结被掩盖(1,2,6)。研究表明,将甘露糖分子引入锝标记的大分子如白蛋白、聚赖氨酸和葡聚糖中,由于淋巴结巨噬细胞的甘露糖受体识别作用,这些探头以前哨淋巴结内可饱和的方式增强了滞留,尽管颗粒尺寸仅为几纳米(7,8)。皮尔梅蒂斯等人合成了一种甘露糖基化纳米化合物DCM20,其具有葡聚糖主链、作为用[Tc(CO)]核心标记的螯合剂的衍生化半胱氨酸以及用于与甘露糖受体结合的甘露糖部分(1)。放射性标记的DCM20(Tc(CO)-DCM20)在注射部位清除迅速,并在前哨淋巴结中有高摄取和滞留。本章总结了用Tc(CO)-DCM2

相似文献

3
New (99m)Tc(CO)(3) mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection.
Mol Pharm. 2012 Jun 4;9(6):1681-92. doi: 10.1021/mp300015s. Epub 2012 May 10.
4
Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping.
Mol Pharm. 2015 Feb 2;12(2):514-9. doi: 10.1021/mp500592e. Epub 2014 Dec 29.
6
Studies toward the biological efficacy of (99m)Tc-labeled dextran-cysteine-mannose ([(99m)Tc(CO)(3)]DCM20) for sentinel lymph node detection.
Cancer Biother Radiopharm. 2012 Aug;27(6):365-70. doi: 10.1089/cbr.2011.1131. Epub 2012 Jun 12.
8
[99mTc]Tilmanocept Lymphscintigraphy after inconclusive [99mTc]Nanocolloid Scan in Breast Cancer.
Nuklearmedizin. 2019 Jun;58(3):282-284. doi: 10.1055/a-0891-7686. Epub 2019 May 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验